← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA4708.2x12.7x19.1x
EV / LTM revenue6970.9x1.9x3.6x
Premium to unaffected price64920%32%52%
Premium to 30-day VWAP12220%37%50%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
041812009: 5 deals, 1 clean on every measure200952010: 66 deals, 16 clean on every measure2010662011: 76 deals, 46 clean on every measure2011762012: 75 deals, 64 clean on every measure2012752013: 81 deals, 71 clean on every measure2013812014: 55 deals, 50 clean on every measure2014552015: 61 deals, 57 clean on every measure2015612016: 66 deals, 63 clean on every measure2016662017: 60 deals, 51 clean on every measure2017602018: 67 deals, 62 clean on every measure2018672019: 63 deals, 59 clean on every measure2019632020: 51 deals, 43 clean on every measure2020512021: 72 deals, 62 clean on every measure2021722022: 60 deals, 54 clean on every measure2022602023: 57 deals, 43 clean on every measure2023572024: 69 deals, 59 clean on every measure2024692025: 57 deals, 47 clean on every measure2025572026: 32 deals, 24 clean on every measure202632
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 18.8x median across 49 dealsHealthcare18.8xn=49Technology: 18.2x median across 96 dealsTechnology18.2xn=96Financials: 17.7x median across 11 dealsFinancials17.7xn=11Real Estate: 17.2x median across 20 dealsReal Estate17.2xn=20Business Services: 13.2x median across 27 dealsBusiness Services13.2xn=27Industrials: 12.9x median across 73 dealsIndustrials12.9xn=73Utilities: 10.8x median across 37 dealsUtilities10.8xn=37Materials: 9.7x median across 22 dealsMaterials9.7xn=22Other: 9.5x median across 19 dealsOther9.5xn=19Energy: 9.5x median across 22 dealsEnergy9.5xn=22Consumer & Retail: 9.5x median across 74 dealsConsumer & Retail9.5xn=74Media & Telecom: 9.4x median across 20 dealsMedia & Telecom9.4xn=20
Deals by sector
Technology: 226 dealsTechnology226Healthcare: 177 dealsHealthcare177Industrials: 136 dealsIndustrials136Consumer & Retail: 117 dealsConsumer & Retail117Financials: 106 dealsFinancials106Business Services: 66 dealsBusiness Services66Real Estate: 51 dealsReal Estate51Utilities: 43 dealsUtilities43Materials: 42 dealsMaterials42Energy: 40 dealsEnergy40Media & Telecom: 40 dealsMedia & Telecom40Other: 29 dealsOther29
Deals by buyer type
Financial sponsor: 123 dealsFinancial sponsor123Strategic: 1073 dealsStrategic1073Management / founder: 2 dealsManagement / founder2Controlling holder: 10 dealsControlling holder10Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 913 dealsUnclassified913
Deals by enterprise value
Under $250m: 361 dealsUnder $250m361$250m to $1bn: 262 deals$250m to $1bn262$1bn to $5bn: 304 deals$1bn to $5bn304$5bn to $20bn: 117 deals$5bn to $20bn117Over $20bn: 20 dealsOver $20bn20Not computed: 9 dealsNot computed9
Deals by industry code
Business Services & Software: 179 dealsBusiness Services & Sof…179Chemicals, Pharmaceuticals & Allied Products: 120 dealsChemicals, Pharmaceutic…120Electronics & Electrical Equipment: 99 dealsElectronics & Electrica…99Instruments, Medical Devices & Optical Goods: 70 dealsInstruments, Medical De…70Industrial Machinery & Computers: 43 dealsIndustrial Machinery & …43Electric, Gas & Sanitary Services: 43 dealsElectric, Gas & Sanitar…43Holding & Other Investment Offices: 38 dealsHolding & Other Investm…38Depository Institutions: 37 dealsDepository Institutions37Insurance Carriers: 35 dealsInsurance Carriers35Communications: 32 dealsCommunications32
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
SP Plus Corp
2023-10-04 · Public merger · $54.00 a share
Metropolis Technologies, Inc.
Strategic
Other$1.4bn12.1x0.8x
n.a.
DEFM14A
All cash
LiveVox Holdings, Inc.
2023-10-03 · Public merger · $3.74 a share
Inc.
Strategic
Technology$297mn.a.2.1x
14%
DEFM14C
All cash
Splunk Inc
2023-09-20 · Public merger · $157.00 a share
Held out of the multiples: EV / LTM EBITDA 353.8x outside 1x to 75x
Cisco Systems, Inc.
Strategic
Technology$25bn353.8x6.4x
29%
DEFM14A
All cash
Avantax, Inc.
2023-09-09 · Public merger · $26.00 a share
Aretec Group, Inc.
Strategic
Financials$1.1bnn.a.2.4x
n.a.
DEFM14A
All cash
Hersha Hospitality Trust
2023-08-27 · Public merger · $10.00 a share
Hersha Hospitality Limited Partnership
Strategic
Real Estate$259m3.3x0.7x
60%
DEFM14A
All cash
Capri Holdings Ltd
2023-08-10 · Public merger · $57.00 a share
Tapestry, Inc.
Strategic
Consumer & Retail$8.3bnn.a.1.5x
n.a.
59% to VWAP
DEFM14A
All cash
SciPlay Corp
2023-08-08 · Take-private · $22.95 a share
Board book on file →
Light & Wonder International, Inc.
Strategic
Technology$2.0bn10.5x2.7x
48%
SC 13E3
All cash
Sovos Brands, Inc.
2023-08-07 · Public merger · $23.00 a share
Campbell Soup Company
Strategic
Consumer & Retail$2.6bn46.1x2.8x
57%
DEFM14A
All cash
EQRx, Inc.
2023-07-31 · Public merger · $25.71 a share
Revolution Medicines
Strategic
Healthcare$11bnn.a.n.a.
n.a.
DEFM14A
All cash
Zhangmen Education Inc.
2023-07-28 · Take-private · $0.56 a share
Held out of every statistic: premium of 178%: distressed or misread; equity value 807 vs fee-table value 9
Board book on file →
Summit Lustre LTD
Strategic
Consumer & Retail$807mn.a.n.a.
178%
SC 13E3
All cash
Reata Pharmaceuticals Inc
2023-07-28 · Public merger · $172.50 a share
Held out of the multiples: EV / LTM revenue 235.6x above 60x
Biogen Inc.
Strategic
Healthcare$5.5bnn.a.235.6x
63%
DEFM14A
All cash
Kaleyra, Inc.
2023-06-28 · Public merger · $7.25 a share
Tata Communications Limited
Strategic
Technology$43mn.a.0.1x
n.a.
DEFM14A
All cash
Amedisys Inc
2023-06-26 · Public merger · $101.00 a share
UnitedHealth Group Incorporated
Strategic
Healthcare$3.6bn18.4x1.6x
29%
DEFM14A
All cash
Quotient Technology Inc.
2023-06-20 · Public merger · $4.00 a share
CB Neptune Holdings, LLC
Strategic
Business Services$399mn.a.1.5x
19%
DEFM14A
All cash
Gelesis Holdings, Inc.
2023-06-12 · Take-private · $0.06 a share
Board book on file →
Puretech Health PLC
Strategic
Healthcaren.a.n.a.n.a.
n.a.
SC 13E3
All cash
Chinook Therapeutics, Inc.
2023-06-11 · Public merger · $40.00 a share
Held out of the multiples: EV / LTM revenue 438.7x above 60x
Novartis AG
Strategic
Healthcare$2.3bnn.a.438.7x
67%
82% to VWAP
DEFM14A
All cash
Limeade, Inc
2023-06-08 · Public merger · $0.42 a share
WebMD Health Corp.
Strategic
Technology$109mn.a.1.9x
n.a.
217% to VWAP
DEFM14A
All cash
Paratek Pharmaceuticals, Inc.
2023-06-06 · Take-private · $2.15 a share
Board book on file →
Novo Holdings A/s
Strategic
Healthcare$336mn.a.2.0x
9%
20% to VWAP
SC 13E3
All cash
Embark Technology, Inc.
2023-05-25 · Public merger · $2.88 a share
Applied Intuition, Inc.
Strategic
Technology$921mn.a.n.a.
n.a.
DEFM14A
All cash
Wireless Telecom Group Inc
2023-05-24 · Public merger · $2.13 a share
Maury Microwave, Inc.
Strategic
Technology$26mn.a.1.3x
n.a.
DEFM14A
All cash
Greenhill & Co Inc
2023-05-22 · Public merger · $15.00 a share
Mizuho Americas LLC
Strategic
Financials$488m35.1x1.9x
121%
DEFM14A
All cash
Emagin Corp
2023-05-17 · Public merger · $2.08 a share
Samsung Display Co., Ltd.
Strategic
Technology$169mn.a.5.7x
n.a.
DEFM14A
All cash
Franchise Group, Inc.
2023-05-10 · Take-private · $30.00 a share
Board book on file →
B. Riley Financial, Inc.
Strategic
Financials$2.4bn18.3xn.a.
32%
SC 13E3
All cash
IVERIC bio, Inc.
2023-04-28 · Public merger · $40.00 a share
Astellas US Holding, Inc.
Strategic
Healthcare$4.9bnn.a.n.a.
64%
DEFM14A
All cash
Satsuma Pharmaceuticals, Inc.
2023-04-16 · Take-private · $0.91 a share
Board book on file →
Shin Nippon Biomedical Laboratories, Ltd.
Strategic
Healthcare-$11mn.a.n.a.
n.a.
SC 13E3
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More